Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
2d
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...
Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Brainstorm Cell Therapeutics (BCLI – Research Report). The ...
Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...
The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...
Long-time Lewisville resident, Yvette Anderson Boyce, 60, passed away at her home on Monday, Sept. 16, following a four-plus-year battle with Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s ...
NeuroSense Therapeutics has been granted a key patent for the formulation of its treatment for amyotrophic lateral sclerosis, or ALS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback